This publication identifies a number of promising practices or actions that health centers can take to mitigate the negative financial impact due to manufacturer actions on health center patients and health center 340B savings.
This toolkit has been designed to assist CHCs in maximizing their 340B program when dealing with the manufacturers who have limited distribution of their medications to contract pharmacies. When the suggestions presented here by peer health centers are considered, your CHC may be able to gain the most benefit from 340B program even under the current circumstances.
Questions? Contact us at email@example.com.
This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $7,287,500 with 0 percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit www.HRSA.gov.